Ken Griffin Zynex Inc Call Options Transaction History

Citadel Advisors LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$7.19 - $10.31 $1,438 - $2,062	200 New	200 $1,000
Q1 2024 May 15, 2024	BUY	$9.86 - $13.74 $17,748 - $24,732	1,800 New	1,800 $22,000
Q3 2023 Nov 14, 2023	SELL	$6.95 - $9.89 $9,035 - $12,857	-1,300 Reduced 92.86%	100 $0
Q2 2023 Aug 14, 2023	BUY	$8.59 - $14.56 $12,026 - $20,384	1,400 New	1,400 $13,000
Q4 2022 Feb 14, 2023	SELL	$8.71 - $14.28 $56,615 - $92,820	-6,500 Reduced 36.11%	11,500 $159,000
Q3 2022 Nov 14, 2022	SELL	$7.19 - $9.91 $82,756 - $114,064	-11,510 Reduced 39.0%	18,000 $163,000

103

8.4M

200

1.5K

Ticker ZYXI
Exchange NASDAQ
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 37,453,400
Market Cap $306M
Description
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and n...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.